For instance, engineered T cells expressing AXL-CAR-T were able to trigger cytokine release and antigen-specific cytotoxicity in triple-negative breast cancer (TNBC), where AXL is overexpressed [29,30]. The gene discussed is AXL; the disease is triple-negative breast carcinoma.